Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Merck
Moodys
Mallinckrodt
McKesson

Last Updated: November 17, 2019

DrugPatentWatch Database Preview

Litigation Details for LEO Pharma A/S v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

See Plans and Pricing

« Back to Dashboard

LEO Pharma A/S v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Docket   Start Trial Date Filed 2018-01-03
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Colm F. Connolly
Jury Demand None Referred To Sherry R. Fallon
Parties BAYER AG; BAYER HEALTHCARE PHARMACEUTICALS INC.; FOAMIX PHARMACEUTICALS LTD.; LEO PHARMA A/S; LEO PHARMA INC.; PERRIGO UK FINCO LIMITED PARTNERSHIP; TEVA PHARMACEUTICALS USA, INC.
Patents 10,117,812; 7,700,076; 8,435,498; 8,722,021; 8,900,554; 9,211,259; 9,265,725
Attorneys Adam L. Perlman; Alexandra D. Valenti; Alice L. Riechers; Anthony David Raucci; Charles T. Cox , Jr.; Christine J. Siwik; Christopher A. Yeager; Christopher P. Galligan; David A. Bilson; Elise M. Baumgarten; Elizabeth J. Holland; Gregory A. Duff; Jack B. Blumenfeld; John C. Phillips , Jr.; Karen Elizabeth Keller; Lauren M. Lesko; Linnea P. Cipriano; Marta M. Chlistunoff; Megan C. Haney; Nathan Roger Hoeschen; Rodger Dallery Smith , II; Stanley E. Fisher; William A. Rakoczy
Firms Morris, Nichols, Arsht & Tunnell; Phillips, Goldman, McLaughlin & Hall, P.A.; Shaw Keller LLP
Link to Docket External link to docket
Small Molecule Drugs cited in LEO Pharma A/S v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for LEO Pharma A/S v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 of U.S. Patent No. 7,700,076 (“the ’076 patent”), U.S. Patent No. 8,435,498 (“the ’498 patent”), U.S.… COUNT I – INFRINGEMENT OF U.S. PATENT NO. 7,700,076 24. Plaintiffs fully incorporate…076 patent, the ’498 patent, the ’021 patent, the ’554 patent, the ’259 patent, or the ’725 patent, respectively…076 patent, the ’498 patent, the ’021 patent, the ’554 patent, the ’259 patent, or the ’725 patent, prior… of the ’076 patent, the ’498 patent, the ’021 patent, the ’554 patent, the ’259 patent, and the ’725 External link to document
0000-00-00 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,700,076 B2; 8,435,498 B2; 8,722,021… 3 January 2018 1:18-cv-00013 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
2018-12-18 67 infringement of United States Patent No. 10,117,812 (“the ’812 patent”) (Exhibit A), arising from the…infringed U.S. Patent No. 7,700,076 (“the ’076 patent”), U.S. Patent No. 8,435,498 (“the ’498 patent”), U.S.…U.S. Patent No. 8,722,021 (“the ’021 patent”), U.S. Patent No. 8,900,554 (“the ’554 patent”), U.S. Patent… The ’812 patent is from the same patent family as the Related Patents. The ’812 patent and the Related…9,211,259 (“the ’259 patent”), and U.S. Patent No. 9,265,725 (“the ’725 patent”) (collectively, “the External link to document
0000-00-00 68 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,117,812 B2 . (Smith, Rodger… 3 January 2018 1:18-cv-00013 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 71 Initial Invalidity Contentions Regarding U.S. Patent No. 10,117,812 filed by Perrigo UK FINCO Limited Partnership… 3 January 2018 1:18-cv-00013 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Medtronic
McKesson
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.